Published May 25, 2017
| Version v1
Patent
Open
CHIMERIC ANTIGEN RECEPTORS RECOGNIZING CANCER-SPECIFIC TN GLYCOPEPTIDE VARIANTS
- 1. University of Chicago
Contributors
Patent applicant:
Description
Disclosed are binding proteins, or fragments thereof, that specifically binds to a cancer-specific glycosylation variant of a protein and to a second epitope on the same protein, to a different protein presented on the same cell, or to a different protein presented on a different cell, such as an encoded polypeptide binding to both a cancer cell and an activated T cell. Also disclosed are polynucleotides encoding such binding proteins, including polynucleotides comprising codon-optimized coding regions and polynucleotides comprising coding regions that are not codon-optimized for expression in a particular host cell. Also disclosed are methods of making the encoded polypeptide and methods of using the polypeptide to treat, prevent or ameliorate the symptom of a disease such as cancer.
Files
US20170145108.pdf
Files
(2.9 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:ac3d3a3485af459f2cfcb5313ec52686
|
2.9 MB | Preview Download |
Additional details
Identifiers
- Patent application number
- US 201515117063 A
- Patent number
- US 2017/0145108 A1
- Other
- oai:uchicago.tind.io:9122
Dates
- Patent filed
-
2015-02-05